CD274 and neoplasm: Expression levels have been shown to vary depending on the location of tissue sample (e.g., primary tumour vs. metastatic site, biopsy tissue vs. surgically resected disease, between one metastatic site and another, or even between different locations within the same tumour deposit), potentially resulting in false-negative reporting of PD-L1 status (34, 50).